TherapeuticsMD, Inc. (TXMD) Gross margin 2016–2023
TherapeuticsMD, Inc. (TXMD) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2023 · since FY2016: 78.4% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 100.0% | +2.0 pp |
| FY2022 | 98.0% | +52.5 pp |
| FY2021 | 45.5% | -29.9 pp |
| FY2020 | 75.4% | -11.9 pp |
| FY2019 | 87.2% | +4.2 pp |
| FY2018 | 83.0% | -1.3 pp |
| FY2017 | 84.3% | +5.9 pp |
| FY2016 | 78.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net incomeTXMD Net marginTXMD Gross profitTXMD Operating incomeTXMD Operating marginTXMD Operating cash flowTXMD Free cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Total liabilitiesTXMD Shareholders’ equityTXMD overview →